首页> 外文期刊>Drug safety: An international journal of medical toxicology and drug experience >Assessing opioid shopping behaviour: A large cohort study from a medication dispensing database in the US
【24h】

Assessing opioid shopping behaviour: A large cohort study from a medication dispensing database in the US

机译:评估阿片类药物的购物行为:来自美国药物分配数据库的大型队列研究

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Risks of abuse, misuse and diversion of opioids are of concern. Obtaining opioid prescriptions from multiple prescribers, known as opioid shopping, is a way in which opioids may be abused and diverted. Previous studies relied on counting the number of prescribers or number of pharmacies a subject goes to in a year to define shopping behaviour, but did not distinguish successive prescribers from concomitant prescribers. Objective: The aim of the study was to assess the frequency of opioid overlapping prescriptions from different prescribers, compare it with diuretics and benzodiazepines, and provide a definition of shopping behaviour that differentiates opioids from diuretics, avoiding the inappropriate flagging of individuals with legitimate use of opioids. Study Design: Population-based cohort study using the IMS LRx database.This database covers 65% of all retail prescriptions in the US and includes mail service and specialty pharmacy provider prescriptions independent of the method of payment. Setting: Ambulatory. Patients: Subjects with at least one dispensing for any type of opioid in 2008. Similar cohorts were created for subjects exposed to benzodiazepines or diuretics.Analyses were performed separately for na?ve subjects and those with prior use. Outcome: Frequency of overlapping prescriptions defined as at least 1 day of overlapping dispensing of prescriptions written by two or more different prescribers at any time during an 18-month period. Results: A total of 25 161 024 subjects exposed to opioids were included, of whom 13.1% exhibited at least one episode of overlapping prescriptions during 18 months of follow-up. Almost 10% of subjects exposed to benzodiazepines and 13.8% of subjects exposed to diuretics exhibited a similar behaviour. Having overlapping prescriptions dispensed by three or more pharmacies differentiates opioids from the other medication classes. Using that criterion, the overall risk of shopping behaviour was 0.18% in subjects exposed to opioids, 0.10% in subjects exposed to benzodiazepines and 0.03% in subjects exposed to diuretics. For opioids, subjects aged between 25 and 64 years exhibited shopping behaviour more commonly (0.25%) than subjects 65 years or older (0.07%), and subjects with a history of prior opioid use exhibited such behaviour more commonly (0.7%) than opioid-na?ve subjects (0.07%). Conclusion: Overlapping of prescriptions is not unique to opioids and therefore a criterion that incorporates number of pharmacies is needed to define shopping behaviour. Having two or more overlapping prescriptions written by different prescribers and filled at three or more pharmacies differentiates opioids from diuretics and likely constitutes shopping behaviour.
机译:背景:阿片类药物的滥用,滥用和转移的风险值得关注。从多个处方者那里获得阿片类药物处方,即所谓的阿片类药物购物,是滥用和转移阿片类药物的一种方式。先前的研究依赖于对受试者一年中去处方药的数量或药房的数量进行定义,以定义购物行为,但并未将连续的处方药与伴随的处方药区分开。目的:该研究的目的是评估来自不同处方者的阿片类药物重叠处方的使用频率,并将其与利尿剂和苯二氮卓类药物进行比较,并提供一种将阿片类药物与利尿剂区别开来的购物行为的定义,避免对正当使用阿片类药物的个人进行不当举报阿片类药物。研究设计:使用IMS LRx数据库进行基于人群的队列研究,该数据库涵盖了美国所有零售处方的65%,其中包括独立于付款方式的邮件服务和专业药房处方。地点:动态。患者:2008年,至少有一种用于任何类型阿片类药物的受试者。针对暴露于苯并二氮杂卓或利尿剂的受试者建立了类似的队列。对初次受试者和先前使用过的受试者分别进行了分析。结果:重叠处方的频率,定义为在18个月内的任何时间,由两个或更多不同处方者共同书写的处方,至少重叠一天。结果:总共包括25 161 024位暴露于阿片类药物的受试者,其中13.1%的受试者在随访18个月中至少出现了一次重复处方。暴露于苯并二氮杂subjects的受试者中几乎有10%和暴露于利尿剂的受试者中有13.8%表现出相似的行为。由三个或更多药房分配的重叠处方可将阿片类药物与其他药物类别区分开。使用该标准,接触阿片类药物的总购物行为风险为0.18%,接触苯二氮类药物的受试者为0.10%,利尿剂的受试者为0.03%。对于阿片类药物,年龄在25至64岁之间的受试者比65岁或65岁以上的受试者(0.25%)表现出更常见的购物行为(0.25%),并且有使用过阿片类药物史的受试者比阿片类药物更常见(0.7%)天真的对象(0.07%)。结论:处方的重叠不是阿片类药物独有的,因此需要一个结合药房数量的标准来定义购物行为。由两个不同处方者撰写并在三个或三个以上药店开具的两个或多个重叠处方将阿片类药物与利尿剂区分开,并可能构成购物行为。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号